A vaccine developer focused on fighting infectious diseases like HSV-2, Pneumococcus and malaria has just gotten a $30 million vote of confidence from investors. Genocea Biosciences says its ATLAS platform mimics the human T cell immune response in the laboratory, allowing it to identify and test T cell antigens in less time and with more […]
Roche is definitely on to something. The world’s largest maker of cancer drugs recently said that 60 percent of the drugs in its pipeline are coupled with companion diagnostics to make treatment more effective. As the healthcare industry pushes to make personalized medicine mainstream, diagnostics have become an even more important piece of the overall […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Nasty microorganisms lurking on bed rails, tables, doorknobs and other surfaces in hospitals are causing a more than $30 billion (PDF) problem for the U.S. healthcare system. This cool-looking device is one of many trying to hunt down these microorganisms in an effort to reduce healthcare-associated infections like MRSA and C. difficile. Xenex Healthcare Services […]
The U.S. will continue to lead the global vaccine market and grow as much as 5.3 percent each year until 2018, according to a new report from Transparency Market Research. With the potential to reach $17.4 billion by 2018, the market is moving toward consolidation, with the most dominant players being Pfizer, GSK, Novartis and […]
The pieces are finally coming together for vascular device startup Catheter Connections. CEO Vicki Farrar said the four-year-old company has secured new patents this summer, hired a new vice president of sales and has gotten back strong infection reduction data in a trial of its anti-infective cap for catheters. It’s also raising a $2 million […]
Imagine a person that develops an acute problem that requires hospitalization and even a time in the ICU. Serious but something that modern medical care can deal with and cure. Until …the patient now develops an unexpected serious infection and despite excellent and appropriate medical care, dies. Unfortunately this scenario is all too common in […]
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.